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Single-channel currents -activated by N-methyl-D-aspartate (NMDA) were characterized using the outside-out patch 
clamp technique in cultured hippocampal cells from the rat. Several conductance states were observed, and the main 
one of 47 pS was further analyzed for channel ifetime and frequency. Open times decreased with hyperpolarization of 
the membrane. In view of recent evidence linking NMDA receptors to central nervous system processes uch as learning 
and memory and ethanol (EtOH) tolerance, the effects of EtOH (0.01-l%, v/v, or u 1.74174 mM) were studied in this 
preparation. Two effects of EtOH could be discerned: (i) at low concentrations (1.74-8.65 mM) an increase in the prob- 
ability of opening CJQ,,) of the NMDA-activated channel currents, without change in the mean channel open time, and 
(ii) at higher concentrations (86.5-174 mM) a decrease in popen with a concomitant decrease in the mean open time. It 
is suggested that EtOH, even at rather low concentrations, may affect important brain functions. 
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1. INTRODUCTION 
The mechanisms by which EtOH affects the cen- 
tral nervous system remain to be fully elucidated. 
Behavioral studies using animals acutely and 
chronically intoxicated with ethanol (EtOH) have 
suggested that the stimulatory effect produced by 
low doses of EtOH appears to be mediated by the 
activation of central dopaminergic transmission 
while an inhibitory effect is related to central 
GABAergic transmission [ 1,2]. More detailed 
analysis indicated that EtOH enhances the open- 
ings of GABA* receptor-gated chloride channels 
[3-61. It has also been shown that stimulation of 
dopaminergic activity could be due to a depression 
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of the activity of the GABAergic mechanisms [2], 
thus relating GABA to both phases of the EtOH 
activity. Indeed, a number of authors postulated a 
role of the GABA system in the development of 
EtOH tolerance and dependence [4,7-91. 
Although the actions of EtOH have been exten- 
sively studied on GABAergic systems, few data ex- 
ist on the effects of EtOH on excitatory amino acid 
systems [ 10,111. N-Methyl-D-aspartate (NMDA) 
receptor/channel complex has been implicated in 
some of the most important functions of the CNS 
such as learning and memory [12,13], and these 
processes have been receptly correlated to the well- 
described phenomenon of tolerance after EtOH 
administration [ I$]. 
In preliminary studies we observed that at low 
concentrations EtOH had an effect on the NMDA- 
activated single currents .[ 151. The objective of this 
work was to study the action of EtOH on the 
NMDA-activated single-channel currents in rat 
hippocampal cells, and also to characterize further 
the NMDA receptor-ion channel. 
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We have observed that EtOH at low concentra- 
tions activated and blocked the NMDA receptor- 
ion channel. These findings suggest hat even at 
low levels EtOH affects important brain functions. 
2. MATERIALS AND METHODS 
2.1. Tissue culture 
The method utilized was basically the one described by 
Aracava et al. [16]. Briefly, female rats (Sprague-Dawley, 
16-18 days of gestation) were killed by cervical dislocation and 
the fetuses placed in cold physiological solution. The cerebral 
hemispheres were isolated and the hippocampi dissected, min- 
ced and incubated with trypsin (0.25%) for 30 min at 35.5OC. 
After the incubation period, the medium was changed to 
modified Eagle’s medium (MEM, Gibco) with 10% horse 
serum, 10% fetal calf serum, glutamine (2 mM) and DNase 
(40 fig/ml). The neurons were dissociated by trituration with a 
Pasteur pipette and plated in a final concentration of 350000 
cells/ml in Petri dishes previously covered with astrocytes 
isolated from DUB mice [17]. 24 h later the culture medium was 
changed to MEM plus 10% horse serum and glutamine (2 mM). 
1 week after plating, FDUR (53 PM) was added to avoid 
background cell proliferation, and after 24 h the medium was 
changed to MEM plus 10% horse serum and glutamine (2 mM). 
The medium was changed twice a week. The hippocampal 
cultures were composed principally of pyramidal cells, as the 
granular cells were not present at this stage of development. For 
recording channel activity, 7-21-day-old cultures were used. 
2.2. Patch-clamp technique 
The recordings of single-channel currents were made using 
the patch-clamp technique [18] in the outside-out configura- 
tion. The microelectrode resistance ranged between 2 and 
7 MO. Recordings were made at room temperature (19-22°C). 
The external solution had the following composition (mM): 165 
NaCl, 5 KCl, 2 CaClz, 5 Hepes (pH 7.3), 310 mosm plus 0.3 PM 
TTX. The internal solution was composed of (mM): 80 CsCl, 
80 CsF, 10 CsEGTA, 10 Hepes, pH 7.3; 320 mosm [19]. An 
LM-EPC 7 patch-clamp system (List Electronic, FRG) was used 
to record the single-channel currents. The data were stored on 
FM tape (Racal 4DS), filtered at 3 kHz and digitized at 
12.5 kHz. The IPROC-2 program was used for analysis of cur- 
rent amplitude and channel open and closed times. Open 
probabilityp,,, was calculated as the sum of all open durations 
during a recording divided by the record length. Because the 
IPROC-2 program (Axon Instruments, Burlingame, CA) ex- 
cludes openings to a multiple conductance level from open time 
histograms an attempt was made to correct the total open time 
for these events; the number of events invalidated because of 
openings to a multiple conductance level was multiplied by the 
mean open time, and this value was added to the sum of the 
open times. Unfortunately, this method still provides an 
underestimation, since two or more openings to a multiple level 
would be counted as only one if they occurred within a single 
open event. The histograms of channel open and closed times 
were fitted using the NFITS program (Axon Instruments). 
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3. RESULTS 
3.1. NMDA-activated single-channel currents 
NMDA-activated single-channel currents 
recorded from cultured hippocampal pyramidal 
neurons are shown in fig.1. Amplitudes were 
voltage-dependent, and the current-voltage plot 
yielded slope conductance values of 47 and 30 pS 
for the two highest conductance states (fig.1). The 
mean channel open time under control conditions 
decreased with hyperpolarization (fig.2). At a 
holding potential of - 70 mV these channels had a 
mean channel open time of 1.39 -I 0.36 ms (n = 14 
patches), and this value remained constant 
regardless of the concentration of NMDA used 
(2.5-10 ,uM). The decrease in mean open time with 
hyperpolarization occurred together with an in- 
crease in the number of flickers, and the duration 
of the flickers showed some voltage dependence. 
At - 70 mV the second component of the closed 
time distribution had a mean of 0.80 f 0.16 ms 
(n = 10 patches), while at - 120 mV this value was 
increased to 1.44 f 0.26 ms (n = 5 patches). Fre- 
quency of openings varied from patch to patch, 
but did not change during the time of recording, 
i.e. no desensitization pattern was seen even at the 
highest (50pM) concentrations of NMDA tested. 
However, at concentrations ~250 pM some degree 
of desensitization was noted (Ramoa and Albu- 
querque, unpublished). 
3.2. EtOH effects on NMDA-activated channel 
currents 
NMDA concentrations were selected based on 
the frequency of channel opening in the patch. The 
data are presented as percentage of the values 
recorded after a stabilization period of at least 
1 min after adding NMDA. Control recordings 
were first made in the presence of NMDA alone 
and then solutions containing test concentrations 
of EtOH (0.01-l%, v/v, or ~1.74-174 mM) were 
added to the bath, allowing at least 1 min to 
achieve homogeneous dilution of EtOH in the 
bath. Several concentrations of EtOH could be 
tested on a single patch, allowing at least 2 min for 
recording at each concentration. When it was 
possible, recording was also made after washing. 
The effects of the low concentrations of EtOH 
(1.74-8.65 mM) tested were not uniform. Usually 
there was an increase in the frequency of openings 
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Fig.1. Samples of NMDA-activated currents at various holding potentials. Amplitude of NMDA (10 FM)-activated single channel 
currents is also plotted vs membrane potential. Channel current amplitude varied linearly with the holding potential, and two 
predominant conductances, a lower one of 30.0 f 2.7 pS (0) and a higher one of 47.1 f 2.1 pS (0) were observed. Data were 
obtained from 4 patches. The standard error is below the resolution of the graph (<O.OWo of the mean). 
reflected as a 48% increase inp,,,,, but in some ex- 
periments instead of an increase in the probability 
of channel opening, a decrease of this parameter 
(21%) was observed (fig.3). When the concentra- 
tion of EtOH was increased 10 times 
(86.5-174 mM), a depressant effect of EtOH on 
the frequency of openings of the NMDA-activated 
channel currents was seen. The pope,, decreased to 
50% of the control values (fig.3). This same 
magnitude of decrease was observed whether the 
recording was made immediately after obtaining 
the control NMDA recordings or at the end of a 
series of concentrations of EtOH. 
The discrimination between the effects of low 
and high concentration of EtOH was also seen on 
the mean open time. The mean open time of the 
NMDA-activated currents was not affected by 
1.74, 8.65 and 17.4 mM of EtOH, but it was de- 
0.1 J 
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Fig.2. Mean open time of NMDA (lOpM)-activated single- 
channel currents. The logarithms of values for channel open 
time in the range of potentials studied were linearly related to 
holding potential, with a positive slope and an e-fold change in 
open time per 45 mV. 
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Fig.3. Samples of NMDA (10 ,cM)-activated single-channel currents. Recordings are from one outside-out patch. The graph shows the 
probability of opening (rroPc,,) is plotted in the inset. The increase in popen was seen in 5 out of 7 patches. The decrease in pawn with 
the low concentrations was seen in 2 out of 7 patches. Because more than one recording was made in the two patches which showed 
no increase, the total number of observations was four. The 50% decrease observed after the higher concentrations of EtOH was seen 
in all patches studied. Holding potential -70 mV, NMDA concentration for the inset ranged from 2.5 to IOpM. 
creased to 85% and 58% of the control values in 
the presence of 86.5 and 174 mM of EtOH, respec- 
tively (figs 4 and 5). 
These effects of EtOH on the frequency and 
open time of NMDA-activated channel currents 
were partly recovered upon washing. 
4. DISCUSSION 
Single-channel currents activated by 2.5-10 PM 
NMDA showed at least three conductance levels, 
the higher ones having conductance of 47 and 
30 pS. Similar values have been reported previous- 
ly [19-211. The currents flickered markedly at 
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hyperpolarized potentials, resulting in a decrease 
in open time with hyperpolarization in the range of 
potentials tested. It is possible that these are 
characteristics of the NMDA-activated channels, 
themselves, but we cannot discard the possibility 
that this behavior could be due to an open channel 
blockade. NMDA could be blocking its own chan- 
nels, or we could be seeing a blockade by Mg2+ 
[22]. Values for mean open time for a given 
holding potential were constant at the different 
concentrations of NMDA used in these ex- 
periments, arguing against the possibility that 
NMDA is acting as an open channel blocker. 
Regarding Mg2+, even though solutions were 
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Fig.4. Effect of EtOH on the mean open time of NMDA- 
activated single-channel currents. Data are from 3-5 patches. 
Holding potential - 80 mV. 
nominally Mg 2+-free, and we used the perfusion 
system for some patches to protect against con- 
tamination by Mg2+ liberated by the cells per se, a 
small amount of this cation may still be available 
that could block the NMDA channels 1221. Indeed, 
the voltage dependence that we observed for the 
flicker durations seems to be in agreement with 
blockade by a charged ion. In contrast, Howe et al. 
[23] recording from cerebellar granule cells of the 
rat found no voltage dependence of duration and 
number of flickers, leading these authors to con- 
clude that the NMDA-activated channels were not 
being blocked by a charged molecule. Preliminary 
experiments using EDTA (5 mM) to chelate Mg2+ 
showed no change in flickering behavior of the 
NMDA-activated currents (Aracava, personal 
communication). More experiments are needed to 
clarify this issue. 
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We have shown that EtOH, in the range of con- 
centrations tested (0.01-l%, v/v, or 
-1.74-174 mM), affected the frequency of open- 
ings and the mean open time of the NMDA- 
activated single-channel currents. While at 
8.65-17.4 mM EtOH, the majority of patches 
showed an increase in frequency, in two out of 
seven patches studied we saw a decrease in fre- 
quency. We can only speculate that more than one 
population of NMDA receptors that exhibit con- 
ductance of 47 pS may exist, only one of which 
responds with an increase in frequency to EtOH. 
Since the facilitatory effect lasted for 5-10 min in 
the presence of EtOH, it is unlikely that an in- 
crease in frequency was missed in these patches 
during the 1 min equilibration before recording. 
Effects of EtOH in rat cerebellar Purkinje cells 
have been shown to be concentration dependent, 
i.e. low concentrations of the drug (4.4 mM) in- 
crease the firing rate and the regularity of the 
cerebellar activity, and high concentration 
(55 mM) depress the activity ]24,25]. In Purkinje 
neurons also, chronic exposure to EtOH 
(19.5 mM) results in a decrease in the respon- 
siveness of these neurons to glutamate and, when 
the treatment is done during development, it alters 
the spontaneous activity of the neurons without 
impairing their morphological differentiation [ 111. 
Similar to our results, the effects seen after acute 
administration of EtOH [lo] were reversible, in 
contrast to results seen after chronic administra- 
tion, when the EtOH effects persist after removal 
of the agent Ill]. 
The concentration of ethanol required to cause 
acute intoxication is L 30 mM and at a concentra- 
0 4 8 0 4 8 0 4 8 
Open Time (msec) 
Fig.5. Open time histograms of NMDA-activated single-channel currents recorded in the presence of 5 PM NMDA plus 8.65 or 
174 mM EtOH. Holding potential - 80 mV. 
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tion of 2 100 mM it has lethal effects [26]. Suzdak 
et al. [6] showed that 220 mM of EtOH stimulate 
Cl- uptake via GABA receptor-coupled chloride 
ion channels in cerebral cortical synaptosomes, but 
subintoxicating concentrations (I 10 mM) poten- 
tiate both muscimol- and pentobarbital-stimulated 
Cl- uptake. In the present work the range of con- 
centrations of EtOH used was 1.74-174 mM, a 
relatively low level when compared to the values 
seen in the literature [6,26]. The effects seen on the 
NMDA-activated channel currents at such a low 
concentration may not be due to unspecific effects 
of EtOH on the membrane lipids themselves. Mac- 
Creery and Hunt [27] showed that the ability of 
EtOH to induce ataxia in rats correlates with its 
membrane/buffer partition coefficient and mem- 
brane disordering properties suggesting that the 
behavioral effects of EtOH were not induced by 
specific binding to a receptor. The range of con- 
centrations of EtOH used in the present work and 
the reversibility of the effects after washing suggest 
that these EtOH effects could be specifically 
related to an action on the NMDA receptor ion 
channel complex. 
Recently, some homology has been proposed 
between different chemically gated channels [28]; 
between some regions of the GABAA receptor and 
the nicotinic receptor this homology reached 62% 
[29]. Structural as well as pharmacological and 
biochemical similarities have been reported 
[28,30]. These findings are not restricted to the 
GABA/nicotinic receptor; resemblances were also 
seen between the nicotinic receptor and the glycine 
receptor [31]. These observations led to the 
hypothesis that the ligand-gated channels are 
derived from a common ancestor, the 
chloride/bicarbonate channel [32]. Because the ac- 
tion of EtOH is well established in the GABAA 
receptor ion channel, the effects of this agent on 
the NMDA-activated channel current could rein- 
force the concept of the super-family of receptors. 
The increase in the frequency of openings of the 
NMDA-activated single channel currents seen at a 
low concentration of EtOH could be the result of 
an increase in the affinity of NMDA for its binding 
site. On the other hand this effect could result 
from the stimulation of presynaptically located 
sites causing the release of endogenous glutamate, 
consequently increasing the frequency of openings 
of the NMDA-activated channel. However, such 
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an effect could result in receptor desensitization 
[33,34], a phenomenon not observed in this study 
with NMDA. 
The decrease in the mean open time of the 
NMDA-activated single currents seen at higher 
concentrations of EtOH could lead to a marked 
decrease in the activity of some central areas 
related to these excitatory amino acids. Thus, the 
ability of EtOH to increase the excitability of the 
glutamate receptor, seen with low concentrations 
of the agent, strongly suggests a stimulatory effect 
of the agent on brain activity mediated by 
glutamate, whose implication in the physio- 
pathological function remains to be elucidated. 
In summary, EtOH, over the range of concen- 
trations tested, seems to have two effects: at low 
concentrations it facilitates the activation of the 
NMDA receptor/ion channel without changing the 
mean open time, but at higher concentrations it 
decreases the frequency of openings and the chan- 
nel lifetime. These actions of EtOH seen at rather 
low concentrations uggest hat NMDA receptors 
could be intimately involved in the lack of con- 
sciousness, coordination and convulsions seen 
after EtOH administration as well as in the 
development of alcohol tolerance. 
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